KININ2018CLE - Confirmed Speakers

August 15, 2017

Jonas Emsley, Nottingham University, Nottingham, England
Structural Biology of Factor XII

Thomas Renne, Karolinska University, Stockholm, Sweden
Polyphosphates in Health and Disease

Owen McCarty, School of Medicine, Oregon Health and Science University, Portland, Oregon, USA
The Physical Nature of Contact Activation

Nicola Mutch, University of Aberdeen, Aberdeen, Scotland
Platelet Polyphosphates & Factor XII

David Gailani, Vanderbilt University, Nashville, Tennessee, USA
Single Chain Factor XIIa

Edward Conway, University of British Columbia, Vancouver, Canada
Polyphosphates and Complement Activation

Evi Stavrou, Case Western Reserve University, Cleveland, Ohio, USA
Neutrophil Factor XII in Inflammation and Thrombosis

Edward Feener, KalVista, Inc. Boston, Massachusetts, USA
Kallikrein Inhibition in Diabetic Macular Degeneration

Con Panousis, CSL Behring, Melbourne, Australia
3F7 and Thrombosis Prevention

Daniel Sexton, Shire, Lexington, Massachusetts, USA
Landelumab, Characterization and Use

Navraj Pannu, Leiden University, Leiden, Netherlands
Structural Basis for C1 Inhibitor Interaction with Polysaccharides

Coen Maas, University Medical Center Utrecht, Netherlands
Making a Better C1 Inhibitor

Marco Cicardi, University of Milan, Milan, Italy
Critical Issues in Understanding Hereditary Angioedema

Bruce Zuraw, University of California at San Diego, San Diego, California, USA
Complexity of Treatment Choices for Hereditary Angioedema

Joao B. Pesquero, Universidade Federal de Sao Paulo, Sao Paulo, Brazil
Angioedema and Kinins

Ursula Quitterer, ETH Zurich and University of Zurich, Zurich, Switzerland
Pathologic Effects of AT1-B2 Receptors Heteromers in Transgenic Models

Michael Bader, Max Delbrück Center for Molecular Medicine (MDC), Buch, Germany
Novel Transgenic Rat Models that Overexpress Endothelial Cell B1 and B2 Receptors

Diane Karpman, Lund University, Lund, Sweden
Role of B1 receptor in Inflammation Associated with Vasculitis

Robson A. S. Santos, Federal University of Minas Gerais, Belo Horizonte, Brazil
Angiotensin-(1-7) and Mas in Vascular Biology

Robert M. Carey, University of Virginia, Charlottesville, Virginia, USA
Angiotensin 2 Receptor in Vascular Biology and Hypertension

Louis Luttrell, Medical College of South Carolina, Charleston, South Carolina, USA
Biased Agonism of RAS Receptors

Duncan J. Campbell, University of Melbourne, Melbourne, Australia
Neprilysin Inhibitors and Bradykinin

John C. Burnett, Mayo Clinic, Rochester, Minnesota, USA
Biochemistry of Neprilysin in Cardiorenal Disease

Nancy J Brown, Vanderbilt University, Nashville, Tennessee, USA
Bradykinin Receptor Antagonism in ACE-Induced Angioedema

Francois Alhenc-Gelas, Paris Descartes Med School, Pierre et Marie Curie Univer, Paris, France
Kallikrein, Kinins, and ACE (kininase II) in Ischemic and Diabetic Disease – New therapies

Julio Scharfstein, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Trypanosoma Cruzi and Bradykinin Receptors

Ana A.S. Pinheiro, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
Bradykinin and Mas Receptors in Invasion by P. Falciparum